Interpreting Protein Language Models: high attention sites predict functional regions

Authors

Pribus, S. J., Altman, R. B., Nayar, G.

Abstract

Computational proteomics has revolutionized biomedical research, guiding targeted experimental exploration to accelerate protein-based mechanistic discovery. Protein Language Models (PLMs) enable scalable, resource-efficient study; through large-scale training on only primary protein sequences, PLMs generate vector representations of protein structure that have been shown to capture biochemical, evolutionary, and structural properties. A core component of PLMs is the attention mechanism, which specifically captures long-range interactions across a protein sequence in attention matrices. Using the Evolutionary Scale Modelling 2 (ESM-2) PLM, we previously developed a novel method to identify "High Attention" (HA) sites. HA sites are specific residues that ESM-2 assigns the most attention to early during encoding. Here, we further characterize these HA sites across structural and functional metrics. Using unsupervised clustering, we find HA sites can be categorized as "structural core", "structural pathogenic", "core pathogenic", or "low-confidence". We further use AlphaMissense pathogenicity predictions and the pan-cancer analysis of whole genomes (PCAWG)-labeled pathogenic variant positions to show that HA sites predict protein regions with high pathogenic risk. Finally, we explore the utility of HA sites for suggesting candidate binding sites, identifying multiple cancer protein examples where HA sites identified regions with previously undiscovered high interaction likelihood and thus potential therapeutic utility. Our work demonstrates the biological interpretability of PLM representations and offers a valuable method to prioritize functionally relevant protein residues for targeted biomedical research.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 05 Aug 2026.

Stats

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.